Ronald Kirk Huntsman, CEO, Director at Vivos Therapeutics, holds 1.81M shares in Vivos Therapeutics (Ticker: VVOS). Most recently, Ronald Kirk Huntsman Bought $15,021 shares of Vivos Therapeutics on Jun 20, 2023 for an estimated value of 8.06K.
What is the percentage of profitable transactions made by Ronald Kirk Huntsman?
The percentage of profitable transactions made by Ronald Kirk Huntsman is 11%.
What is the average return per transaction made by Ronald Kirk Huntsman?
The average return per transaction made by Ronald Kirk Huntsman is -64.00%.
What stocks does Ronald Kirk Huntsman hold?
Ronald Kirk Huntsman holds: VVOS stocks.
What was Ronald Kirk Huntsman’s latest transaction?
Ronald Kirk Huntsman latest transaction was an Informative Buy of $8.06K.
What was Ronald Kirk Huntsman's most profitable transaction?
Ronald Kirk Huntsman’s most profitable transaction was an Informative Buy of VVOS stock on December 28, 2022. The return on the trade was 19.60%.
What is Ronald Kirk Huntsman's role in Vivos Therapeutics?
Ronald Kirk Huntsman's role in Vivos Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.